NCT03863184: Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL
- State
- Under way
- Phase
- Phase 2
- People
- 37 taking part
- Started
- 11 Oct 2019
- Primary completion
- 25 Apr 2024
- Arms
- ALO in Combination
- Results
- Posted on the registry
- 5 Mar 2019: Trial registered
- 11 Oct 2019: Trial started
- 6 Jun 2025: Trial results posted